NCT01260233

Brief Summary

The purpose of this study is to determine whether a perioperative smoking cessation program, implemented at least 3 weeks prior to elective surgery, is effective in increasing rates of smoking cessation or reduction. Intraoperative and immediate postoperative complications will also be compared.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
168

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2010

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2010

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

December 13, 2010

Completed
2 days until next milestone

First Posted

Study publicly available on registry

December 15, 2010

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2012

Completed
1.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2013

Completed
Last Updated

August 26, 2013

Status Verified

August 1, 2013

Enrollment Period

1.6 years

First QC Date

December 13, 2010

Last Update Submit

August 22, 2013

Conditions

Keywords

smoking cessationcomplicationscigarettespreoperativeperioperativesurgeryeducationnicotine replacement therapy

Outcome Measures

Primary Outcomes (1)

  • smoking cessation

    Smoking cessation is defined as exhaled carbon monoxide (CO) of equal to or less than 7ppm on the day of surgery.

    date of surgery

Secondary Outcomes (6)

  • smoking cessation/reduction

    day of surgery

  • Intraoperative complications and immediate post-operative complications

    day of surgery

  • Time until PACU readiness for discharge / actual time in PACU

    day of surgery

  • Unanticipated hospital admission

    day of surgery

  • Hospital length of stay

    until hospital discharge

  • +1 more secondary outcomes

Study Arms (2)

Control

NO INTERVENTION

No intervention. Patients will receive standard of care.

Smoking cessation program

EXPERIMENTAL

Receives smoking cessation program

Other: Smoking cessation program

Interventions

Smoking cessation program includes: * brief smoking cessation counselling by preadmission nurse (less than 5 minutes) * smoking cessation brochures * referral to the Smokers' Helpline telephone advice line, run by the Canadian Cancer Society * free transdermal nicotine replacement therapy for 6 weeks Smokers of 10 cigarettes per day or more receive 4 weeks of nicoderm 21mg/day, 1 week of 14mg/day and 1 week of 7mg/day Smokers of less than 10 cigarettes per day receive 4 weeks of nicoderm 14mg/day and 2 weeks of 7mg/day

Also known as: nicoderm, transdermal nicotine replacement therapy, nicotine replacement patch
Smoking cessation program

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • smokers (defined as those that smoke at least 2 cigarettes per day and have smoked within the last 7 days)
  • over age 18
  • presenting to preadmission clinic at St. Joseph's Health Care at least 3 weeks prior to scheduled date of surgery

You may not qualify if:

  • less than age 18
  • poor proficiency in English language
  • pregnant
  • breastfeeding
  • unable to consent due to severe mental illness or dementia
  • actively participating in another smoking cessation trial

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

St. Joseph's Health Care

London, Ontario, N6A 4V2, Canada

Location

Related Publications (1)

  • Lee SM, Landry J, Jones PM, Buhrmann O, Morley-Forster P. Long-term quit rates after a perioperative smoking cessation randomized controlled trial. Anesth Analg. 2015 Mar;120(3):582-587. doi: 10.1213/ANE.0000000000000555.

MeSH Terms

Conditions

SmokingTobacco UseSmoking Cessation

Interventions

NicotineTobacco Use Cessation Devices

Condition Hierarchy (Ancestors)

BehaviorHealth Behavior

Intervention Hierarchy (Ancestors)

Solanaceous AlkaloidsAlkaloidsHeterocyclic CompoundsPyridinesHeterocyclic Compounds, 1-RingTherapeutics

Study Officials

  • Philip Jones, MD, FRCPC

    Western University, Canada

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

December 13, 2010

First Posted

December 15, 2010

Study Start

October 1, 2010

Primary Completion

May 1, 2012

Study Completion

August 1, 2013

Last Updated

August 26, 2013

Record last verified: 2013-08

Locations